Givaudan Active Beauty has unveiled Illuminyl 388, a biotech-enhanced molecule designed through cell-free glycosylation to address the challenges of skin pigmentation for all skin types.
Crafted through a unique biocatalysis process from EGCG1, green tea's most iconic antioxidant, the molecule is said to deliver a holistic luminous effect.
The Swiss maker says at the heart of Illuminyl 388 is a commitment to inclusivity in skincare innovation.
The active is designed to simultaneously target multiple skin pigmentation pathways and is reinforced by additional prebiotic activity to meet the needs of diverse skin types from Africa, Asia, India, and Europe.
Givaudan undertook in-depth and global clinical studies, engaging over 200 volunteers comprised of four diverse skin tones: African, Asian, Indian and Caucasian.
The studies found Illuminyl 388 is able to improve skin radiance and enhance skin tone & luminosity in two weeks; reduce pigmentation spots in one month; and enhance skin tone homogeneity, even tackling stubborn age spots.
Its sugar moiety enables its absorption via cellular glucose receptors, while conferring on the molecule a prebiotic activity which stimulates the in-situ release of a niacin-derivative by the skin microflora.
“We are not only targeting all the major pigmentation pathways but we also trigger the skin microbiota to produce whitening postbiotics,” said Givaudan Active Beauty scientific director of biotechnology Daniel Auriol.
“Whether it's improving skin radiance and luminosity, promoting even skin tone, or reducing pigmentation spots, Illuminyl 388 outperforms traditional benchmarks such as vitamin C,” he added.
